Suppressing mutant tumor protein 53 (mtp53) and poly-ADP-Polymerase (PARP) by PARP-inhibiting therapies could be an effective way to interrupt the development of triple negative breast cancer cells.
from Medindia Health News https://ift.tt/38QTbJ1
Thursday 30 January 2020
Targeted Treatment for Breast Cancer May Lie Existing Drugs
Suppressing mutant tumor protein 53 (mtp53) and poly-ADP-Polymerase (PARP) by PARP-inhibiting therapies could be an effective way to interrupt the development of triple negative breast cancer cells.
from Medindia Health News https://ift.tt/38QTbJ1
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment